TABLE 2.
Clinical and epidemiological characteristics of patients stratified by the genovariants detected (L2, L2b, L2bV1, L2bV4, and L2bV7)
| L2 (%) | L2b (%) | L2bV1 (%) | L2bV4 (%) | L2bV7 (%) | P | |
|---|---|---|---|---|---|---|
| Symptoms/signs | N = 146 | N = 126 | N = 42 | N = 26 | N = 28 | |
| Pain | 66 (45.2) | 72 (57.1) | 21 (50.0) | 12 (46.2) | 13 (46.4) | 0.255 |
| Purulent discharge | 50 (34.2) | 36 (28.6) | 9 (21.4) | 5 (19.2) | 9 (32.1) | 0.233 |
| Bleeding | 50 (34.2) | 49 (38.9) | 13 (30.9) | 6 (23.1) | 11 (39.3) | 0.429 |
| Edema | 46 (31.5) | 50 (39.7) | 18 (42.9) | 9 (34.6) | 11 (39.3) | 0.409 |
| Ulcer | 11 (7.5) | 15 (11.9) | 5 (11.9) | 3 (11.5) | 3 (10.7) | 0.573 |
| None | 37 (25.3) | 20 (15.9) | 10 (23.8) | 4 (15.4) | 5 (17.9) | 0.225 |
| HIV serological status | N = 144 | N = 136 | N = 44 | N = 26 | N = 33 | |
| Positive | 108 (75) | 84 (61.8) | 37 (84.1) | 12 (46.2) | 22 (66.7) | 0.001 |
| HCV serological status | N = 97 | N = 118 | N = 36 | N = 26 | N = 30 | |
| Positive | 21 (21.6) | 16 (13.6) | 5 (13.9) | 2 (7.7) | 4 (13.3) | 0.273 |
| N = 101 | N = 118 | N = 40 | N = 25 | N = 27 | ||
| Concomitant STI | 46 (45.5) | 54 (45.8) | 16 (40) | 12 (48.0) | 10 (37.0) | 0.911 |
| Syphilis | 17 (16.8) | 15 (12.7) | 6 (15) | 3 (12.0) | 0 | 0.852 |
| N. gonorrhoeae | 30 (29.7) | 35 (29.7) | 12 (30) | 8 (32.0) | 8 (29.3) | 0.996 |
| C. trachomatis | 6 (5.9) | 5 (4.2) | 0 | 2 (8.0) | 1 (3.7) | 0.6 |
| Others (HPV, HSV-2) | 1 (0.9) | 10 (8.5) | 0 | 8 (32.0) | 2 (7.4) | 0.017 |
| N = 81 | N = 108 | N = 26 | N = 25 | N = 23 | ||
| Previous STIs | 68 (83.9) | 95 (88.0) | 19 (73.1) | 24 (96.0) | 21 (91.3) | 0.114 |
| Syphilis | 54 (66.7) | 69 (63.9) | 14 (53.8) | 12 (48.0) | 18 (78.3) | 0.292 |
| N. gonorrhoeae | 37 (45.7) | 50 (46.3) | 10 (38.5) | 21 (84.0) | 11 (47.8) | 0.003 |
| C. trachomatis | 20 (24.7) | 22 (20.4) | 5 (19.2) | 9 (36.0) | 6 (26.1) | 0.376 |
| LGV | 11 (13.6) | 17 (15.7) | 1 (3.8) | 3 (12.0) | 0 | 0.499 |
| Others (HPV, HSV-2) | 37 (24.7) | 17 (15.7) | 4 (15.4) | 5 (20.0) | 2 (8.7) | 0.462 |
| Patient origin | N = 194 | N = 144 | N = 51 | N = 26 | N = 31 | |
| Spain | 112 (57.7) | 92 (63.9) | 35 (68.6) | 12 (46.2) | 19 (61.3) | 0.175 |
| Latin America | 68 (35.1) | 45 (31.3) | 13 (25.5) | 11 (42.3) | 12 (38.7) | 0.409 |
| Other European countries | 11 (5.7) | 4 (2.8) | 3 (5.9) | 2 (7.7) | 0 | 0.394 |
| Other | 3 (1.5) | 3 (2.1) | 0 | 1 (3.8) | 0 | 0.474 |
| Drug user | N = 76 | N = 101 | N = 26 | N = 26 | N = 22 | |
| 38 (50.0) | 67 (66.3) | 16 (61.5) | 16 (61.5) | 16 (72.8) | 0.179 | |
| Sexual behavior | N = 121 | N = 130 | N = 40 | N = 25 | N = 25 | |
| MSM | 118 (97.5) | 125 (96.2) | 40 (100) | 24 (96.0) | 24 (96.0) | 0.701 |
| Bisexual | 1 (0.8) | 4 (3.1) | 0 | 1 (4.0) | 1 (4.0) | 0.379 |
| MSW | 2 (1.7) | 0 | 0 | 0 | 0 | 0.355 |
| Male sex workers | 12 (9.9) | 11 (8.5) | 4 (10.0) | 2 (8.0) | 2 (8.0) | 0.972 |